Drug · DIN 02527049

PREVNAR 20

0.5 ML SINGLE-DOSE PREFILLED SYRINGE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since July 8, 2022; first marketed July 8, 2022.

Drug Identification Number (DIN): 02527049
Company (DIN owner): Pfizer Canada UlcKirkland, Quebec, Canada
Schedule: Schedule D
Dosage form: Suspension
Route: Intramuscular
Therapeutic class (ATC): Pneumococcus, purified polysacc.antigen conjugated J07AL02
Class: Human
Record last updated: August 14, 2026

Active ingredients

As listed in the Drug Product Database.

Ingredient	Strength	Per
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B	4.4 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F	2.2 MCG	0.5 ML
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F	2.2 MCG	0.5 ML
CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN	51 MCG	0.5 ML